PDF(Pubmed)
Abstract：
BACKGROUND: The COVID-19 pandemic and the associated social restrictions may have disrupted the provision of essential services, including family planning (FP) and contraceptive services. This protocol is adapted from a generic study protocol titled \"Health systems analysis and evaluations of the barriers to availability and readiness of sexual and reproductive health services in COVID-19 affected areas,\" conducted by the World Health Organization (WHO) Department of Reproductive Health and Research.
OBJECTIVE: This study aims to assess the availability and use of FP and contraceptive services in primary health facilities during and after the COVID-19 pandemic; assess the risk perceptions of COVID-19 stigma, barriers to access, and quality of services from clients\' and providers\' perspectives in the COVID-19-affected areas; and assess the postpandemic recovery of the facilities in the provision of FP and contraceptive services.
METHODS: In-depth interviews will be conducted with clients-women in the reproductive age group and their male partners who visit the selected health facilities for FP and contraceptive services-and health providers (the most knowledgeable person on FP and contraceptive service provision) at the selected health facilities. Focus group discussions will be conducted with clients at the selected health facilities and in the community. The in-depth interviews and focus group discussions will help to understand clients\' and health service providers\' perspectives of FP and contraceptive service availability and readiness in COVID-19-affected areas. A cross-sectional health facility assessment will be conducted in all the selected health facilities to determine the health facility infrastructure\'s ability and readiness to provide FP and contraceptive services and to capture the trends in FP and contraceptive services available during the COVID-19 pandemic. Scientific approval for this study is obtained from the WHO Research Project Review Panel, and the WHO Ethics Review Committee has given ethical approval in the 3 countries.
RESULTS: Using a standardized research protocol will ensure that the results from this study can be compared across regions and countries. The study was funded in March 2021. It received ethics approval from the WHO Ethics Review Committee in February 2022. We completed data collection in September 2022. We plan to complete the data analysis by March 2023. We plan to publish the study results by Summer 2023.
CONCLUSIONS: The findings from this study will provide a better understanding of the impact of the COVID-19 pandemic on FP and contraceptive services at the facility level, which will help policy makers and health managers develop and strengthen FP policies and services in health facilities to be more responsive to community needs.
UNASSIGNED: DERR1-10.2196/43329.
OBJECTIVE: This study aims to assess the availability and use of FP and contraceptive services in primary health facilities during and after the COVID-19 pandemic; assess the risk perceptions of COVID-19 stigma, barriers to access, and quality of services from clients\' and providers\' perspectives in the COVID-19-affected areas; and assess the postpandemic recovery of the facilities in the provision of FP and contraceptive services.
METHODS: In-depth interviews will be conducted with clients-women in the reproductive age group and their male partners who visit the selected health facilities for FP and contraceptive services-and health providers (the most knowledgeable person on FP and contraceptive service provision) at the selected health facilities. Focus group discussions will be conducted with clients at the selected health facilities and in the community. The in-depth interviews and focus group discussions will help to understand clients\' and health service providers\' perspectives of FP and contraceptive service availability and readiness in COVID-19-affected areas. A cross-sectional health facility assessment will be conducted in all the selected health facilities to determine the health facility infrastructure\'s ability and readiness to provide FP and contraceptive services and to capture the trends in FP and contraceptive services available during the COVID-19 pandemic. Scientific approval for this study is obtained from the WHO Research Project Review Panel, and the WHO Ethics Review Committee has given ethical approval in the 3 countries.
RESULTS: Using a standardized research protocol will ensure that the results from this study can be compared across regions and countries. The study was funded in March 2021. It received ethics approval from the WHO Ethics Review Committee in February 2022. We completed data collection in September 2022. We plan to complete the data analysis by March 2023. We plan to publish the study results by Summer 2023.
CONCLUSIONS: The findings from this study will provide a better understanding of the impact of the COVID-19 pandemic on FP and contraceptive services at the facility level, which will help policy makers and health managers develop and strengthen FP policies and services in health facilities to be more responsive to community needs.
UNASSIGNED: DERR1-10.2196/43329.
摘要：
背景：COVID-19大流行和相关的社会限制可能扰乱了基本服务的提供，包括计划生育和避孕服务。该方案改编自名为“对COVID-19受影响地区性健康和生殖健康服务的可用性和准备性的障碍进行卫生系统分析和评估”的通用研究方案，由世界卫生组织生殖健康和研究部进行。
目的：本研究旨在评估在COVID-19大流行期间和之后基层医疗机构计划生育和避孕服务的可用性和利用情况，评估对COVID-19污名的风险认知，进入的障碍，以及来自COVID-19受影响地区的客户和提供者的服务质量，并评估大流行后提供计划生育和避孕服务的设施的恢复情况。
方法：这项研究将在印度进行，尼日利亚和坦桑尼亚由印度医学研究委员会-国家生殖和儿童健康研究所，伊洛林大学教学医院和伊法卡拉健康研究所，分别。在每个国家,研究地点将根据地理位置选择，计划生育和避孕服务的组织以及COVID-19大流行可能严重影响服务提供的流行状况。本研究采用定量和定性相结合的方法。将与客户（育龄妇女及其访问选定的计划生育和避孕服务保健设施的男性伴侣）和选定的保健提供者（关于计划生育和避孕服务提供的最有见识的人）进行深入访谈。设施。在选定的医疗机构和社区与客户进行焦点小组讨论。深入访谈和焦点小组讨论将有助于了解客户和医疗服务提供者对COVID-19受影响地区FP和避孕服务可用性和准备情况的看法。将在所有选定的医疗机构中进行横断面医疗机构评估，以确定医疗机构基础设施提供FP和避孕服务的能力和准备程度，并掌握COVID-19大流行期间FP和避孕服务的趋势。这项研究的科学批准来自世卫组织研究项目审查小组，世卫组织伦理审查委员会已在这三个国家给予伦理批准。
结果：使用标准化的研究方案将确保该研究的结果可以跨地区和国家进行比较。
结论：这项研究的结果将使人们更好地了解COVID-19大流行对设施一级计划生育和避孕服务的影响，这将帮助政策制定者和卫生管理人员制定和加强计划生育政策和服务，通过加强保健设施中的计划生育服务提供，更符合社区需求。
UNASSIGNED：DERR1-10.2196/43329。
目的：本研究旨在评估在COVID-19大流行期间和之后基层医疗机构计划生育和避孕服务的可用性和利用情况，评估对COVID-19污名的风险认知，进入的障碍，以及来自COVID-19受影响地区的客户和提供者的服务质量，并评估大流行后提供计划生育和避孕服务的设施的恢复情况。
方法：这项研究将在印度进行，尼日利亚和坦桑尼亚由印度医学研究委员会-国家生殖和儿童健康研究所，伊洛林大学教学医院和伊法卡拉健康研究所，分别。在每个国家,研究地点将根据地理位置选择，计划生育和避孕服务的组织以及COVID-19大流行可能严重影响服务提供的流行状况。本研究采用定量和定性相结合的方法。将与客户（育龄妇女及其访问选定的计划生育和避孕服务保健设施的男性伴侣）和选定的保健提供者（关于计划生育和避孕服务提供的最有见识的人）进行深入访谈。设施。在选定的医疗机构和社区与客户进行焦点小组讨论。深入访谈和焦点小组讨论将有助于了解客户和医疗服务提供者对COVID-19受影响地区FP和避孕服务可用性和准备情况的看法。将在所有选定的医疗机构中进行横断面医疗机构评估，以确定医疗机构基础设施提供FP和避孕服务的能力和准备程度，并掌握COVID-19大流行期间FP和避孕服务的趋势。这项研究的科学批准来自世卫组织研究项目审查小组，世卫组织伦理审查委员会已在这三个国家给予伦理批准。
结果：使用标准化的研究方案将确保该研究的结果可以跨地区和国家进行比较。
结论：这项研究的结果将使人们更好地了解COVID-19大流行对设施一级计划生育和避孕服务的影响，这将帮助政策制定者和卫生管理人员制定和加强计划生育政策和服务，通过加强保健设施中的计划生育服务提供，更符合社区需求。
UNASSIGNED：DERR1-10.2196/43329。
